Rasha Aboelhassan shared a post on LinkedIn:
”Jenny Seligmann.
Neoadjuvant chemotherapy therapy for localized colon cancer.
Beautiful slide for presenting how do patient pathways change if there’s no MDT: patients do not get chance for PCR by neoadjuvant chemotherapy before surgery.”
Source: Rasha Aboelhassan/LinkedIn
Rasha Aboelhassan is a Senior Oncology Consultant at Nasser Institute Hospital. In addition to her clinical role, she volunteers as a reviewer for the World Journal of Surgical Oncology, contributing to advancements in the field and is in the Editorial Staff of Egyptian Journal of Human Genetics.
